Pharma Firm Seeks Green Light to Import Controlled Drugs
Published Date: 2/26/2025
Notice
Summary
Catalent Pharma Solutions, LLC wants to officially import certain controlled substances. This means they’re asking the government’s permission to bring in these special drugs safely and legally. If approved, it could affect companies and patients relying on these medicines, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Catalent Applies to Import Controlled Drugs
Catalent Pharma Solutions, LLC applied to be registered as an importer of certain controlled substances. If approved, companies and patients who rely on those medicines could be affected, and the notice states there are no immediate cost changes announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in